You are here: Industry Insights > Gamma

News List

Pizzie Succeeds Dr. Steve Burton as President & Chief Scientific Officer Gamma Biosciences
June 15, 2021
Gamma Biosciences, a global life sciences company serving the advanced therapy market, today announced the appointment of Terry Pizzie as Chief Executive Officer (CEO) of operating company Astrea Bioseparations.
Janssen COVID-19 Vaccine can protect against variants of concern europeanpharmaceuticalreview
June 11, 2021
Trial shows the single-shot Janssen COVID-19 Vaccine generates robust immune responses against several COVID-19 variants.
Gamma Biosciences Acquires Stake in Mirus Bio contractpharma
May 19, 2021
Gamma Biosciences has agreed to make a controlling investment in Mirus Bio, a developer of biomimetic, cell-adaptive lipid-polymer nanocomplexes (LPNCs) for nucleic acid delivery based in Madison, WI.
Gamma Biosciences Makes Key Management Hires PharmaSources.com
March 25, 2021
Gamma Biosciences, a global life sciences company serving the advanced therapy market, announced two additions to the senior management team of Astrea Bioseparations.
Univercells Technologies Names CEO contractpharma
March 18, 2021
Univercells S.A. and Gamma Biosciences have appointed Mathias Garny as the Chief Executive Officer of Univercells Technologies, a global provider of next-gen bioprocess technologies.
Univercells, Univercells Technologies and Gamma Biosciences announce Mathias Garny as new CEO of Univercells Technologies PharmaSources.com
March 16, 2021
Univercells S.A., Univercells Technologies, and Gamma Biosciences are pleased to announce that effective March 15, 2021, Mathias Garny has been appointed as the Chief Executive Officer of Univercells Technologies, a Univercells company and global ...